Second malignancy status is a risk factor for death in adolescent and young adults (AYAs) (ages 15–39) with thyroid cancer (TC). This study investigates whether age at primary malignancy (PM) is an independent predictor of overall survival (OS) for AYA patients diagnosed with secondary TC who have survived ≥5 years from their PM.


Briana J. Lau, MD

Melanie Goldfarb, MD, MS, FACS, FACE

Read the abstract